A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis

Birmingham

Phoenix

Berkeley

Los Angeles

Orange

San Diego

Torrance

Denver

Washington D.C.

Brandon

Clearwater

Lakeland

Miami

Orlando

Tampa

Augusta

Chicago

Oak Park

Springfield

Indianapolis

Des Moines

Iowa City

Kansas City

Lexington

Lake Charles

New Orleans

Shreveport

Portland

Baltimore

Boston

Springfield

Ann Arbor

Detroit

Minneapolis

Saint Lous

Reno

East Orange

New Brunswick

Great Neck

Manhasset

New Hyde Park

New York

The Bronx

Chapel Hill

Greensboro

Winston-Salem

Akron

Toledo

Portland

Hershey

Philadelphia

Pittsburgh

Providence

Memphis

Houston

San Antonio

Falls Church

Seattle

Madison

Milwaukee

Brussels

Ghent

Liège

Ottignies

Yvior

Budapest

Debrecen

Debrecend

Miskolc

Pécs

Szeged

Vác

's-Hertogenbosch

Apeldoorn

Breda

Groningen

Nijmegen

Rotterdam

Gdansk

Krakow-Nowa Huta

Poznan

Sosnowiec

Szczecin

Warsaw

Wroclaw